I'd like to open an account http://fuq.in.net/ fuq .com It works by attaching Herceptin to a drug called DM1,developed by ImmunoGen, which interferes with cancercell growth. ImmunoGen will receive a $5 million milestonepayment from Roche following the Japanese approval.